Studies have shown that Salidroside can inhibit HCC metastasis by suppressing the activation of the Notch1 signalling pathway (Lu et al., 2019), and also inhibit HCC viability and induce apoptosis by activating endoplasmic reticulum stress (Ding et al., 2020). This evidence concerns the gene NOTCH1 and hepatocellular carcinoma.